46.46.0
Оптовая торговля фармацевтическими товарами
152
Общество с ограниченной или дополнительной ответственностью
79994
Субъекты предпринимательства, не вошедшие в структуры органов государственного и хозяйственного управления
1726287
Республика Узбекистан, город Ташкент, Яккасарайский район
Stability rating:
Tax debt:
Is a large taxpayer:
Has a license:
Abuses the right to reduce VAT payable:
Is a resident of the IT Park:
Rating of participants in the electronic public procurement system:
Developer rating:
Included in the unified register of unscrupulous performers:
Information found about participation in government procurement as a supplier or customer
Supplier
6
Customer
0
Коротко о компании
INWARD PHARM has been operating since 2017 in the Оптовая торговля фармацевтическими товарами industry. The director is KOVALENKO ANJELA MARTUNIKOVNA. The company belongs to the Microcompany category. Its primary activity is Оптовая торговля фармацевтическими товарами. The company has 1 from $count_of_founders from other countries, one of whom owns a 100% stake. $count_of_licensing_text. The company has no registered property., $register_text, and 1134 similar companies, indicating a highly competitive market.
Stability rating:
Tax debt:
Is a large taxpayer:
Has a license:
Abuses the right to reduce VAT payable:
Is a resident of the IT Park:
Rating of participants in the electronic public procurement system:
Developer rating:
Included in the unified register of unscrupulous performers:
No data on related organizations
No data on licenses
No data on real estate
Коротко о компании
INWARD PHARM has been operating since 2017 in the Оптовая торговля фармацевтическими товарами industry. The director is KOVALENKO ANJELA MARTUNIKOVNA. The company belongs to the Microcompany category. Its primary activity is Оптовая торговля фармацевтическими товарами. The company has 1 from $count_of_founders from other countries, one of whom owns a 100% stake. $count_of_licensing_text. The company has no registered property., $register_text, and 1134 similar companies, indicating a highly competitive market.